Cardiovascular benefits of early sodium‐glucose cotransporter 2 inhibitor use for diabetics with acute myocardial infarction: A nationwide cohort study — Sheng‐Fan Wang (2025) | RDL Network
Cardiovascular benefits of early sodium‐glucose cotransporter 2 inhibitor use for diabetics with acute myocardial infarction: A nationwide cohort study
Article 2025 en
Authors
SW
Sheng‐Fan Wang
TC
Tien-Min Chan
YL
Yu‐Hsuan Lee
Abstract
1 min read
Early SGLT2i use in diabetics experiencing acute MI reduced cardiovascular risk, supporting its potential therapeutic use.
Xinyi Gao, Nan Zhang, Lei Lü, Tianyu Gao, Oscar Hou In Chou, Wing Tak Wong, Carlin Chang, Abraham Ka Chung Wai, Professor Gregory Lip, Qingpeng Zhang, Gary Tse, Tong Liu, Jiandong Zhou
Discussion(0)
No comments yet. Be the first to comment.